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Volume 53, Number 1 Abstracts 253Conclusions: Thirty-day VTE risk can be quantified in the outpatient
surgery population using a simple risk-scoringmodel. Aggressive chemopro-
phylaxis may be considered in patients with higher risk. However, further
research is necessary to examine the risks, benefits, and cost of chemopro-
phylaxis for outpatient surgery.
Table.
Risk factor
Adjusted odds ratio
(95% CI) P value
Male gender 1.04 (0.77-1.40) .819
General anesthesia 1.38 (0.95-2.00) .091
Arthroscopic surgery 4.87 (2.88-8.21) .001
Abdominal laparoscopy 1.15 (0.72-1.82) .555
Current pregnancy 8.91 (1.11-71.24) .035
Active cancer 5.38 (2.33-12.41) .001
Congestive heart failure 3.73 (0.43-32.21) .231
Chronic obstructive
pulmonary disease
1.24 (0.49-3.13) .648
Diabetes requiring medication 0.86 (0.51-1.45) .567
Central vascular disease 1.40 (0.84-2.33) .192
Peripheral vascular disease 0.73 (0.17-3.14) .642
Current smoker 0.99 (0.67-1.46) .940
Renal failure on dialysis 0.70 (0.16-3.09) .636
Prior operation within 30 days 1.09 (0.40-2.99) .872
Invasive venous procedure 13.42 (9.56-18.84) .001
Age
40 years Reference —
41-60 years 1.98 (1.24-3.16) .004
60 years 2.57 (1.57-4.20) .001
Body mass index
25 Reference —
25-40 1.04 (0.74-1.45) .836
40 1.85 (1.10-3.09) .019
Total operative time
60 minutes Reference —
60-120 minutes 1.12 (0.82-1.52) 0.494
120 minutes 1.68 (1.02-2.77) 0.043
Vena-caval Filters: Review of Indications and Practices at a University
Hospital
R. J. Meisner, N. Labropoulos, A. P. Gasparis, and A. Tassiopoulos, Stony
Brook University Hospital, Stony Brook, NY
Background: Vena cava filter (VCF) use has been increasing in recent
years, particularly after the advent of retrievable filters. A significant number
of VCF appear to be utilized outside the defined indications for this
procedure. This so-called prophylactic VCF placement is particularly con-
troversial, as it is not supported by solid clinical data but is applied liberally in
“high-risk” patients (multiple trauma, morbid obesity). The aim of thisstudy was to investigate the current practice on VCF use at our own
institution.
Methods: Consecutive patients with VCF placement over a 2-year
period (2007 to 2009) at a university hospital were reviewed. Patient
demographics, filter type, retrieval, complications, indications for the pro-
cedure, and department performing the procedure were collected in all
patients.
Results: A total of 244 patients underwent VCF placement of which
159 were retrievable and 84 were permanent. Fifty-four percent of patients
had the VCF placed for an absolute indication, 14% for a relative indication,
and 32% for prophylaxis. Of those patients with a retrievable filter, only 14
(9%) had it removed. Eight patients had a complication of VCF placement,
while there were no complications of filter retrieval. Two of the eight
patients had a major complication: death and right ventricle injury. The
other six complications were considered minor, such as hematoma, filter
migration, and misdeployment. The Department of Trauma and Surgical
Critical Care (TSCC) placed the majority of VCF (n  107), followed by
Vascular Surgery (n  77) and Interventional Radiology (n  60). VCF
placement for prophylaxis alone without absolute indication was 57% from
the TSCC, 18.3% from Interventional Radiology (P  .0001), and 5.2%
from Vascular Surgery (P  .0001 compared with TSCC and P  .025
compared with Interventional Radiology).
Conclusions: The results of this study indicate that as many as 32% of
VCF placed are placed for prophylaxis. A very low percent of VCF is
retrieved. The majority of VCF at this university were placed by the TSCC.
These practices are not in accordance to strict evidence-based guidelines for
VCF placement. This is likely the practice at many other large US university-
based hospitals necessitating strategies for reducing their placement.
Venous Disease and the Effects of Increasing BodyMass Index: Results
from the National Venous Screening Program
C. J. Moore,a R. B. McLafferty,a M. Lentz,b J. R. Schneider,c A. Roupeni-
an,d J. Heller,e W. Bohannon,f and M. Passman,g The Southern Illinois
University, Springfield, Ill,a the National Venous Screening Program, Balti-
more, Md,b the Central Dupage Hospital, Winfield, Ill,c the Vein and Laser
Center NE, Plymouth, Mass,d the Johns Hopkins Vein Center,
Baltimore, Md,e the Scott and White Memorial Hospital and Clinic,
Temple, Tex,f and the University of Alabama, Birmingham, Ala.g
Objective: To determine differences in venous disease across a spec-
trum of body mass index (BMI) from participants in the National Venous
Screening Program (NVSP).
Methods: Utilizing the prospectively maintained database from the
NVSP, statistical analysis was performed to examine differences between
participants according to standard BMI group designations. Data points for
comparison included demographics, thromboembolic (venous thromboem-
bolism) risk assessment, venous quality of life (CIVIQ2), duplex evaluation,
CEAP classification, and venous clinical severity score. A P value of less than
0.01 was considered statistically significant.
Results: From 2005 to 2010, the NVSP has screened 7227 Americans.
BMI category distribution included underweight (UW; BMI 18.5) 1.3%;
normal weight (NW; BMI 18.5-24.9) 34.9%; overweight (OW; BMI 25-
29.9) 34.9%; obese (OB; BMI 30-34.9) 16.6%; morbidly obese (MOB;
BMI 35-39.9) 7.8%; and super morbidly obese (SMOB; BMI 40) 4.7%.
Significant increases in BMI occurred incrementally in diabetes (NW: 4.9%
to SMOB: 25.2%) and hypertension (NW: 22.9% to SMOB: 54.3%). Mean
venous thromboembolism risk assessment scores significantly increased in-
crementally (NW: 3.32 to SMOB: 4.12). Mean quality-of-life scores signif-
icantly increased incrementally (NW: 20.3 to SMOB: 29.02). This observa-
tion was related to differences in limitations of activity. Mean CEAP scores
demonstrated significant incremental increases (NW: 1.49, OW: 1.54, OB:
1.64, MOB: 1.86, SMOB: 2.01). Mean venous clinical severity score scores
significantly increased incrementally (NW: 2.80 to SMOB: 4.58). Duplex
data demonstrated a significantly higher percentage of common femoral vein
reflux in the UW group compared with the overweight classes (UW: 26.04%
to SMOB: 18.69%).
Conclusions: Americans participating in the NVSP show worsening of
venous disease across most objective measures as BMI increases. The pres-
ence of common femoral vein reflux appears to be less with increasing BMI,
and brings in to question the appropriateness of this limited duplex exami-
nation in this population versus calf-muscle pump dysfunction. As obesity
rates climb at a rapid rate, the morbidity and mortality from venous disease
could markedly worsen. This information remains vital across all levels of
health care and further provides objective data to promote programs to
prevent obesity.
Prospective Multi-Center Study of Reliability in Vascular Laboratory
Testing of Venous Reflux
F. Lurie, The Kistner Vein Clinic and the University of Hawaii, Honolulu,
Hawaii
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tic test for reflux in veins of lower extremities, and to examine if some of the
elements of this test can be standardized in order to improve reproducibility.
Methods: This is a prospective multi-center study sponsored by the
American Venous Forum Foundation. Vascular laboratories from 11 centers
participated in protocol development, educational intervention, and data
collection.
Repeatability studies were performed as a duplicate test within 2 weeks
between replicates performed by the same technologist, at the same time of
the day, using the same reflux provoking maneuver, and with patient at the
same position. Repeatability was separately examined for different combina-
tions of patient position, reflux-inducing maneuvers, and time of the test.
Reproducibility was examined by two different technologists, who
performed the test at the same time of the day, using the same reflux
provoking maneuver, and with the patient at the same position.
Facilitated reproducibility was studied by examining the same patients
by two different technologists immediately after an educational intervention
at the central laboratory.
In order to examine potential for decreasing in variability of results,
limits of agreement between two duplex scans were studied by changing
three elements of the test: time of the day (morning vs afternoon), patient’s
position (standing vs supine), and reflux initiation (manual vs automatic
compression-decompression).
Results: A total of 51 patients were examined by different technolo-
gists during four sessions at the central laboratory. At the time of this abstract
submission, an additional 68 patients were examined at participating labo-
ratories.
Overall repeatability was 97.7%, with higher values for superficial veins
and lower for deep veins. Reproducibility was lower, which indicates a
potential for improvement by standardization. This was confirmed by better
reproducibility after educational intervention (facilitated reproducibility).
The element of the test contributing to most significant variability was the
time of the test.
Conclusions: Duplex ultrasound test for venous reflux is repeatable,
but the reproducibility can be improved by standardization and training.
Reflux Time on Air Plethysmography is Shortened in Patients with
Worsening Chronic Venous Insufficiency
C. R. Lattimer, M. Azzam, E. Kalodiki, and G. Geroulakos, The Ealing
Hospital and Imperial College London, London, United Kingdom
Background: The venous filling index (VFI), when elevated, is a
measure of global venous reflux in the calf. Treatments that successfully
abolish reflux normalize the value to under 2 mL/s. Duplex-derived reflux
time (RT) at the sapheno-femoral junction (SFJ) has been shown to increase
with disease severity, and its reduction has been used as an indicator of
treatment success. Our hypothesis is that the stimulus to arrest reflux occurs
when the leg approaches venous capacity. The shorter the RT, the sooner
the leg is subjected to the effects of maximal venous hypertension. Our aim
was to investigate the direction of the relationship between RT estimated
from air plethysmography (APG) and the VFI, a validated indicator of
disease severity.Methods: Ninety-three consecutive patients with primary SFJ reflux
(0.5 seconds) and great saphenous vein reflux (0.5 seconds) awaiting
endovenous treatment were included in the study. Patients with SFJ incom-
petence, deep venous reflux, or a history of a deep vein thrombosis were
excluded. Baseline parameters (median, range) included age (mean, 48
years; range, 22-78 years), averaged great saphenous vein diameter at three
sites (mean, 7.5 mm; range, 4-12 mm), and the clinical component of the
CEAP classification (C3, C2-C6). A gravitational challenge was applied to
an ‘emptied’ leg with the venous reservoir supported with a sensor cuff at an
initial pressure of 6 mm Hg. RT was estimated using the software (ACI
Medical, SanMarcos, CA) as the time taken to reach 90% of the total venous
volume, from the rapid filling phase seen on the monitor.
Results: Median and interquartile range of RT and VFI were 20
seconds (14) and 4.7 mL/s (4.3), respectively. Using APG, estimated reflux
time is inversely related to VFI in patients with chronic venous insufficiency
(P  .0005, Spearman’s rho, linear R2  .634; Fig). Furthermore, shorter
reflux time were observed in patients with worsening C scores (P  .001)
and increasing great saphenous vein diameters (P  .0005).
Conclusions: Increasing great saphenous vein diameters may contrib-
ute to a faster rate of reservoir refilling (VFI). This results in a shorter RT
with a worseningC score. The effects of maximal venous hypertension occur
after the end of RT when the reservoir is full, so reflux time measured by air
plethysmography may indicate more severe disease. Simultaneous duplex
and air plethysmography studies are required to support these findings.
Incidence and Risk Factors for Development of Varicose Veins in the
General Population: Edinburgh Vein Study
L. A. Robertson,a S. Boghossian,a C. J. Evans,b A. J. Lee,c P. L. Allan,a V.
Ruckley,a and F. G. R. Fowkes, aThe University of Edinburgh, Edinburgh,
United Kingdom,a the National Health Service Lothian, Edinburgh, United
Kingdom,b and the University of Aberdeen, Aberdeen, United Kingdom.c
Background: Numerous studies have reported on the frequency of
varicose veins in the general population (prevalence) and associated lifestyle
factors but very few have investigated, longitudinally, the development of
new varicose veins (incidence). The aim of this study was to measure the
incidence of varicose veins in the adult population and identify factors that
increase the future risk of an individual to acquire varicose veins.
Methods: The study was a population cohort in which a random
sample of 1566 men and women aged 18 to 64 years, examined at baseline
in the Edinburgh Vein Study, were invited to have a 13-year follow-up
examination. Assessment included clinical classification of venous disease
using CEAP, duplex scanning to assess incompetence of venous valves, body
mass index, and questionnaire on venous history and lifestyle factors.
Results: Eight hundred eighty study participants took part in the
follow-up study and underwent clinical examination (response rate, 60%).
Of the 555 participants who had no trunk varicose veins at baseline, 101
developed C2 trunk varicose veins in any leg during the 13-year follow up.
The annual incidence rate of trunk varicose veins was 1.35%. The incidence
in men and women was similar with respective rates of 1.31% and 1.39% per
year (P  .45). The risk of developing new varicose veins appeared to
increase with age (incidence rate, 0.73% per annum in 18-34 years; 1.23% in
35-44 years; 1.62% in 45-54 years, and 1.93% in 55-64 years). Increased
body mass index was also associated with incidence of varicose veins (inci-
dence rate, 1.06% per annum in underweight; 1.28% normal weight; 1.41%
overweight, and 1.54% obese). The incidence rate in those with no family
history of varicose veins was 1.07% compared with 1.60% in those with a
family history, but this finding was not statistically significant. Number of
pregnancies was a significant risk factor, with an incidence rate of 1.24% per
year in women who had never been pregnant, increasing to 2.11% per year in
those who had been pregnant four times (P  .02).
Conclusion: The Edinburgh Vein Study is one of the first to measure
the adult incidence of trunk varicose veins and to examine, longitudinally,
factors which increase the risk of varicose veins. The associations found
between risk factors and incident disease provides stronger evidence of
causality than those in prevalence studies. Further analysis of other risk
factors, including venous incompetence, and the impact of changing risk
factors over time will be presented.
Progression of Chronic Venous Disorders: Results from the Bonn Vein
Study
F. Panniera and E. Rabeb, The University of Cologne, Cologne, Germany,a
and the University of Bonn, Bonn, Germany.b
Background: Chronic venous disorders (CVD) are among the most
common diseases in Germany. In the Bonn Vein Study I (BVS I), conducted
in 2000, 3072 participants of the general population of the city of Bonn and
two rural townships, aged 18 to 79 years, took part in this study (1350 men,
1722 women). Participants were selected via simple random sampling from
the registries of residents. In this follow-up study 6.6 years later, the same
population was investigated again. The aim was to identify the incidence and
